Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 818 of 1,261

  1. US 8715710

    Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron

    Heron Therapeutics, Inc. · Granted May 6, 2014 · Expires May 1, 2034

    granted

  2. US 8715682

    Means for the inhibition of anti-beta1-adrenergic receptor antibodies

    Julius-Maximillians-Universitat Wurzburg, A Germany University · Granted May 6, 2014 · Expires May 1, 2034

    granted

  3. US 8715679

    Pili from Mycobacterium tuberculosis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 6, 2014 · Expires May 1, 2034

    granted

  4. US 8716321

    Methods for dosing an orally active 1,2,4-oxadiazole

    PTC THERAPEUTICS, INC. · Granted May 6, 2014 · Expires May 1, 2034

    granted

  5. US 8716294

    Methods for treating inflammatory conditions

    Melior Discovery, Inc. · Granted May 6, 2014 · Expires May 1, 2034

    granted

  6. US 8709464

    Porous objects having immobilized encapsulated biomolecules

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  7. US 8710030

    Phosphonate compounds

    The Regents of the University of California · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  8. US 8710185

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  9. US 8710064

    2-aryl-4-quinazolinones and their pharmaceutical compositions

    China Medical University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  10. US 8710075

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  11. US 8710031

    Compounds for nonsense suppression and methods for their use

    PTC THERAPEUTICS, INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  12. US 8710081

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  13. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  14. US 8710004

    Stable liquid VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  15. US 8709784

    Use of Lactobacillus for liver protection

    China Medical University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  16. US 8710017

    Human and mouse targeting peptides identified by phage display

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  17. US 8709995

    Method for eliciting an immune response to human telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  18. US 8709478

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  19. US 8709476

    Compositions of quaternary ammonium compounds containing bioavailability enhancers

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  20. US 8709444

    Live-attenuated compositions for bacterial infections

    Northwestern University · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  21. US 8709452

    Synthetic bone grafts

    The Regents of the University of California · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  22. US 8709417

    Combination immunotherapy for the treatment of cancer

    BOARD OF REGENTS · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  23. US 8709342

    Antimicrobial flush solutions

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  24. US 8709433

    Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.